IFG
GMAB icon

Independent Financial Group’s Genmab GMAB Stock Holding History

Independent Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,232
Closed -$221K – 1585
2026
Q1 		$221K Sell
8,232
-163
-2% -$4.88K 0.01% 1334
2025
Q4 		$259K Sell
8,395
-173
-2% -$5.39K 0.01% 1223
2025
Q3 		$263K Buy
+8,568
New +$209K 0.01% 1148

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Independent Financial Group's GMAB Position: Q2 2026 in Review

Independent Financial Group sold out of Genmab (GMAB) in Q2 2026, closing a stake of 8,232 shares — an estimated $221K sold.

Independent Financial Group first reported a position in GMAB in Q3 2025 and held it in 3 quarters. The position peaked at $263K in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Independent Financial Group reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Independent Financial Group sold 8,232 Genmab shares in Q2 2026, an estimated $221K.
  • Independent Financial Group first reported a position in Genmab in Q3 2025 and held it in 3 quarters.
  • Independent Financial Group's Genmab position peaked at $263K in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.